ASIA PACIFIC SILK ROAD INVESTMENT CO LTD

Add to a list

Inactive Instrument

Asia Pacific Silk Road Investment Co Ltd Stock Hong Kong S.E.

0767

BMG6853V2817

Valuation: Asia Pacific Silk Road Investment Co Ltd

Market Cap	245M 31.26M 27.17M 25.29M 23.22M 43.85M 2.98B 44.53M 298M 117M 1.49B 117M 115M 4.98B	P/E 2024	-3.29x	P/E 2025	-17.7x
Enterprise Value	226M 28.87M 25.1M 23.36M 21.45M 40.5M 2.76B 41.13M 275M 108M 1.37B 108M 106M 4.6B	EV / Sales 2024	0.56x	EV / Sales 2025	2.38x
Free-Float	46.65%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Asia Pacific Silk Road Investment Co Ltd

04-13	Zhong Ji Longevity to Form AI Vision Health JV Firm	MT
04-13	Zhong Ji Longevity Science's unit entered into JV agreement with Guangdong Liangjingjing Technology	RE
03-26	Zhong Ji Longevity Science posts FY loss attributable HK$16.8 million	RE
03-26	Zhong Ji Longevity Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-10	Zhong Ji Longevity Science Group Limited Announces Appointment of Ms. Tam Mei Chu as Independent Non-Executive Director and Audit Committee, Remuneration Committee, Nomination Committee, the Risk Management Committee and the Share Award Committee Member, Effective February 10, 2026	CI
12-02	Zhong Ji Longevity Science to Buy 25% Stake in Boutique Stem Cell Center	MT
12-01	Zhong Ji Longevity Science to buy 25% of Asian Integrated Cell Laboratory at HK$300 million	RE
11-27	Zhong Ji Longevity Science Group Limited Announces Board and Committee Changes, Effective 27 November 2025	CI
25-10-20	Zhong Ji Longevity's CEO Steps Down, Successor Named; Shares Jump 4%	MT
25-10-17	Zhong Ji Longevity Science appoints Yan Li as CEO	RE
25-10-17	Zhong Ji Longevity Science Group Limited Announces Chief Executive Officer Change, Effective from 17 October 2025	CI
25-10-17	Zhong Ji Longevity Science Group Limited Announces Board Changes, Effective from 17 October 2025	CI
25-09-15	Zhong Ji Longevity Science Partners With Hainan Boao to Establish Oncology Hub; Shares Gain 2%	MT

More news

Press Releases: Asia Pacific Silk Road Investment Co Ltd

21-08-30	Zhong Ji Longevity Science : Announces 2021 Interim Results	AQ
21-05-12	Zhong Ji Longevity Science : VOLUNTARY ANNOUNCEMENT REGISTRATION OF IMPORTANT PATENTS RELATED TO CANCER SCREENING APPROVED BY THE PATENT REGISTRY OF THE INTELLECTUAL PROPERTY DEPARTMENT OF THE GOVERNMENT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION	PU
21-05-12	Zhong Ji Longevity Science : VOLUNTARY ANNOUNCEMENT COOPERATION AGREEMENT	PU
21-05-12	Zhong Ji Longevity Science : (1) PLACING OF NEW SHARES UNDER GENERAL MANDATE; AND (2) CONNECTED TRANSACTION IN RELATION TO SUBSCRIPTION OF NEW SHARES UNDER SPECIFIC MANDATE	PU
21-04-30	Zhong Ji Longevity Science : CHANGE OF DIRECTORS APPOINTMENT OF CHIEF EXECUTIVE OFFICER CHANGES OF MEMBERS OF BOARD COMMITTEES AND CHANGE OF AUTHORISED REPRESENTATIVE	PU

More press releases

Managers and Directors: Asia Pacific Silk Road Investment Co Ltd

Manager	Title	Age	Since
Li Yan CEO	Chief Executive Officer	54	2025-10-16
Ning Chen CIO	Chief Investment Officer	51	2022-02-27
Yuk Hong Yeung SEC	Corporate Secretary	36	2023-05-30

Director	Title	Age	Since
Li Yan CHM	Chairman	54	2020-12-15
Yi Wu He BRD	Director/Board Member	61	2021-08-12
Xiaoshuang Li BRD	Director/Board Member	51	2021-08-30

More insiders

Zhong Ji Longevity Science Group Ltd, formerly Asia Pacific Silk Road Investment Co Ltd, is an investment holding company principally engaged in the longevity science and money lending business. The Company mainly operates its business through five segments. The Longevity Science segment is engaged in longevity science research, longevity medical testing, longevity biological products, longevity management services and member division. The Money Lending segment is engaged in the money lending business and the provision of credits. The Securities and Other Investment segment is mainly engaged in the holding of equity investments and investment in short to long-term financial assets. The Property Investment segment is mainly engaged in the investment in properties for rental income and for potential capital appreciation. The Financial and Investment Advisory segment is mainly engaged in the provision of financial and investment consulting services.

Employees

Sector

Consumer Lending

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASIA PACIFIC SILK ROAD INVESTMENT CO LTD	-.--%	-.--%	-	-	31.26M
BAJAJ FINANCE LIMITED	+8.32%	+12.68%	+29.51%	+56.32%	74.33B
ROCKET COMPANIES, INC.	-2.71%	-1.15%	-12.66%	+18.02%	36.5B
BAJAJ FINSERV LTD.	+6.27%	+8.12%	+4.16%	+26.95%	33.98B
SHRIRAM FINANCE LIMITED	+1.93%	+4.16%	+65.90%	+176.67%	25.8B
SYNCHRONY FINANCIAL	-1.79%	+3.96%	+8.78%	+119.43%	24.66B
SOFI TECHNOLOGIES, INC.	-0.97%	-0.91%	-27.77%	+42.45%	21.04B
JIO FINANCIAL SERVICES LIMITED	+3.85%	+9.27%	-22.11%	-	17.74B
TATA CAPITAL LIMITED	+1.25%	+6.87%	-	-	16.14B
CHOLAMANDALAM INVESTMENT AND FINANCE COMPANY LIMITED	+4.31%	+7.19%	+27.96%	+63.46%	16.55B
Average	+2.31%	+4.78%	+9.22%	+71.90%	29.64B
Weighted average by Cap.	+3.64%	+5.32%	+13.07%	+65.30%

	2024	2025
Net sales	169M 21.5M 18.69M 17.4M 15.97M 30.17M 2.05B 30.63M 205M 80.49M 1.02B 80.76M 78.99M 3.43B	126M 16.08M 13.98M 13.01M 11.95M 22.56M 1.54B 22.91M 153M 60.2M 764M 60.39M 59.07M 2.56B
Net income	-34.73M -4.43M -3.85M -3.58M -3.29M -6.21M -423M -6.31M -42.24M -16.58M -210M -16.63M -16.27M -706M	-16.75M -2.14M -1.86M -1.73M -1.59M -3M -204M -3.04M -20.37M -8M -102M -8.02M -7.85M -340M
Net Debt	-28.73M -3.66M -3.19M -2.96M -2.72M -5.14M -350M -5.22M -34.94M -13.71M -174M -13.76M -13.46M -584M	-18.73M -2.39M -2.08M -1.93M -1.77M -3.35M -228M -3.4M -22.78M -8.94M -114M -8.97M -8.77M -381M

Asia Pacific Silk Road Investment Co Ltd Stock Hong Kong S.E.

Stocks